NCT02706587

Brief Summary

The purpose of this study is to determine whether early neuromuscular electrical stimulation is effective in the prevention of neuromuscular weakness in critical ill patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2016

Completed
20 days until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 11, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

September 13, 2016

Status Verified

September 1, 2016

Enrollment Period

2.1 years

First QC Date

February 10, 2016

Last Update Submit

September 12, 2016

Conditions

Keywords

Critical illness polyneuropathyNeuromuscular Electrical Stimulation

Outcome Measures

Primary Outcomes (1)

  • Medical resuscitation council (MRC) score

    up to 25 months. From date of randomization to the date of ICU discharge

Secondary Outcomes (3)

  • Total duration of mechanical ventilation (days)

    up to 25 months. From date of randomization to the date of ICU discharge

  • Length of ICU stay and hospital stay.

    up to 25 months. From date of randomization to the date of ICU discharge or hospital discharge

  • Type of hospital discharge

    up to 25 months. From date of randomization to the date of hospital discharge

Study Arms (2)

Neuromuscular electrical stimulation

EXPERIMENTAL

NEMS is delivered bilaterally to the quadriceps femoris muscle using a portable battery-powered stimulator (Rehab 400, Cefar Compex, France). The electrodes are placed on the motor points of vastus medialis and vastus lateralis muscles. Electrical stimuli of 45Hz (pulse width: 380 µseconds; 6 seconds on with 1.5 second rise time; and 0.75 seconds fall time.; 5 seconds off). The current is adjusted to ensure maximum tolerable muscle contraction The protocol is applied twice daily for 25 minutes, five days a week.

Device: Neuromuscular electrical stimulation

Sham Control

SHAM COMPARATOR

No electrostimulation

Device: Sham control

Interventions

NEMS is delivered bilaterally to the quadriceps femoris muscle using a portable battery-powered stimulator (Rehab 400, Cefar Compex, France). The electrodes are placed on the motor points of vastus medialis and vastus lateralis muscles. Electrical stimuli of 45Hz (pulse width: 380 µseconds; 6 seconds on with 1.5 second rise time; and 0.75 seconds fall time.; 5 seconds off). The current is adjusted to ensure maximum tolerable muscle contraction The protocol is applied twice daily for 25 minutes, five days a week.

Neuromuscular electrical stimulation

No electrostimulation

Sham Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patient
  • Aged of 18 or more
  • With an intended ICU stay of at least 72 hours
  • Mechanically ventilated

You may not qualify if:

  • Age less than 18 years
  • Pregnant women
  • Preexisting neuromuscular disease
  • Patient bearing a pace maker or an implantable defibrillator.
  • Poly traumatism and/or leg fracture.
  • End stage disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Insitut Mutualiste Montsouris

Paris, 75014, France

RECRUITING

Related Publications (4)

  • Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, Markaki V, Zervakis D, Nanas S. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74. doi: 10.1186/cc8987. Epub 2010 Apr 28.

    PMID: 20426834BACKGROUND
  • Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014 Apr 24;370(17):1626-35. doi: 10.1056/NEJMra1209390. No abstract available.

    PMID: 24758618BACKGROUND
  • Needham DM, Truong AD, Fan E. Technology to enhance physical rehabilitation of critically ill patients. Crit Care Med. 2009 Oct;37(10 Suppl):S436-41. doi: 10.1097/CCM.0b013e3181b6fa29.

    PMID: 20046132BACKGROUND
  • Kho ME, Truong AD, Brower RG, Palmer JB, Fan E, Zanni JM, Ciesla ND, Feldman DR, Korupolu R, Needham DM. Neuromuscular electrical stimulation for intensive care unit-acquired weakness: protocol and methodological implications for a randomized, sham-controlled, phase II trial. Phys Ther. 2012 Dec;92(12):1564-79. doi: 10.2522/ptj.20110437. Epub 2012 Mar 15.

    PMID: 22421734BACKGROUND

MeSH Terms

Conditions

Polyneuropathies

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Christian Lamer, MD

    Institut Mutualiste Montsouris, Paris, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christian Lamer, MD

CONTACT

Celine Menez, PT

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2016

First Posted

March 11, 2016

Study Start

March 1, 2016

Primary Completion

April 1, 2018

Study Completion

June 1, 2018

Last Updated

September 13, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations